sulbactam


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to sulbactam: cefoperazone, Tazobactam

sul·bac·tam

 (sŭl-băk′tăm)
n.
A compound, C8H11NO5S, that inhibits action of the enzyme beta-lactamase, thus counteracting bacterial resistance to beta-lactam antibiotics. It is used in its sodium form in combination with antibiotics such as amoxicillin to treat infections caused by antibiotic-resistant bacteria.

[sul-, of unknown origin + -bactam, suffix for inhibitors of beta-lactamase; see tazobactam.]
References in periodicals archive ?
'Earlier in April, we initiated the global ATTACK (Acinetobacter Treatment Trial Against Colistin) Phase 3 pivotal trial evaluating a fixed-dose combination of sulbactam plus durlobactam, or SUL-DUR (ETX2514SUL), as a potential treatment for carbapenem-resistant Acinetobacter baumannii infections.
Tenders invited for injection,linezolid 2mg/ml,100ml/bottle, tablet,ampicillin 220mg + sulbactam 147mg,4/bottle, injection,ampicillin 1g + sulbactum 0.5g
Preseptal and orbital cellulitis: 15-year experience with sulbactam ampicillin treatment.
coli isolates, the sensitivity pattern towards, Cefepime Tazobactam was 90%, Cefepime--32%, Piperacillin Tazobactam -75%, Cefoperazone sulbactam 71%, Carbapenem- 91%, and Amikacin- 92%.
The prime objective of this study was to evaluate safety and efficacy of Cefoperazone + Sulbactam (CPS) and Cefotaxime + Sulbactam (CTS) combinations used in the treatment of complicated UTI.
Resistance for other antibiotics such as sulbactam ampicillin 22 (68.8%), Doxycycline 14 (43.8%), cefipime 31 (96.9%), minocycline 11 (34.4%), tazobactam piperacillin 26 (81.3%), ciprofloxacin 31 (96.1%), gentamicin 20 (62.5%), amikacin 16 (50%), trimethoprim-sulfamethoxazole 28 (87.5%), Meropenem 23 (71.9%) and Imepenem 25 (78.1%) was found.
To date, colistin (polymyxin E) or polymyxin B-based combinations are recommended as treatments for CRAB because almost all strains of CRAB remain sensitive to polymyxins [5], while sulbactam and fosfomycin have better pharmacokinetic profiles with moderate and low protein binding.
Other antibiotics tested were: imipenem, meropenem, tazobactum, amikacin, cefoperazone sulbactam, gentamicin, cefepime, ceftazidime, co-amoxiclav, ticarcillin, aztreonam, cefoperazone, co-trimoxazole, cefotaxime, cefixime, ceftriaxone, pipemidic acid and ampicillin.
ETX2514 exhibited particularly promising activity in combination with sulbactam against Acinetobacter baumannii, including hard-to-treat carbapenem-resistant and colistin-resistant strains, and with imipenem against carbapenem-resistant Enterobacteriaceae (CRE) and Pseudomonas aeruginosa.
Asimismo, senala que generalmente son resistentes a las penicilinas (amoxicilina y ampicilina); sin embargo, la resistencia a amoxicilina-acido clavulanico y ampicilina-sulbactam en este estudio fue de 44.8 y 10.4%, respectivamente, debido a que ambas aminopenicilinas estaban asociadas a un agente inhibidor de betalactamasas, como son el acido clavulanico y el sulbactam.